Peripheral Perfusion and Tissue Oxygenation Improvement Induced by Antihypertensive Medication Combined with Lipoidoproteinosis Treatment
The presence of microcirculatory disorders (i.e. increase in blood viscosity) as well as increased aggregation rate of erythrocytes has been described (1,2) in non-treated hypertensive patients. The increased aggregation rate has been linked to microvasculopathy and hyperfibrinogenemia frequently present in treated hypertensive patients with metabolic disturbances (such as diabetes, lipoidoproteinosis) (3,4,5). Lipoidoproteinosis, haemorheological and clotting disorders are often the underlying base for serious pathology (ictus, myocardial infarction, etc.) complicating hypertension (6). It is noted that hypertension itself not only represents an independent atherogenic risk factor, but also low “shear stress” within the vessel wall and in addition the level of systolic-diastolic oscillation favours the formation of atherosclerotic patches. All these events are notably increased in the presence of other risk factors for cardiovascular pathology such as smoking, diabetes, blood hyperviscosity and lipoidoproteinosis (7). Furthermore, microcirculatory disorders in hypertensive patients are often associated with a reduction in peripheral oxygen delivery (8). Reduction of blood pressure values and metabolic disturbances in hypertensive patients may improve peripheral perfusion and cellular oxygen delivery.
KeywordsHypertensive Patient Peripheral Arterial Occlusive Disease Peripheral Perfusion Uncertain Objectivity Lipid Pattern
Unable to display preview. Download preview PDF.
- 1.Harris I., Loughlin G., The viscosity of blood in high blood pressure. Am. J.Med. 1980, 23:451–464.Google Scholar
- 2.Lorient-Roudat M.F., Roudat R., Freyburger G.L. Hemorheological abnormalities in essential hypertension. Clin. Hemorheol. 1987, 7:537.Google Scholar
- 3.Petraliot A., Malatino L.S., Fione C.F. Erythrocyte aggregation in different stages of arterial hypertension. Tromb. Haemost. 1985, 54:555.Google Scholar
- 4.Tsinahdzvbishvili B., Beritashvili N., Mcheolishvili G., Erythrocyte aggregability in essential hypertension. Abstract book, Proc. 1. ICCH/8 ECCH Vienna 1993, 13 — 3:401.Google Scholar
- 5.Cicco G., Dolce E., Mancini M., Pirrelli A., Atherosclerosis and hemorheology in hypertension; Organ damage. Medit. J. Surg. Med. 1994, 3: 131–138.Google Scholar
- 6.McGill M.C., Adria S. Stella J., Corbonell L.M. General Undings of international atherosclerosis. Project Lab. Inv. 1968, 18:498.Google Scholar
- 7.Kannel W.B., Wolf P.A., McGee D.L. Systolic blood pressure arterial, rigidity and risk of stroke. The Framingham study. J. Am. Med. 1981, 245: 1225.Google Scholar